1. Improve utilization & adherence to GL recommended therapies in CV prevention.
2. Improve identification and treatment of FH.
3. Improve use of partnerships and registries for care.
Friday, December 7, 2018 - 12:00pm to 1:00pm
Laurence S. Sperling, MD, FACC, FAHA, FACP, FASPC
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation